Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP178411.RAZZKdCJ_tHPQzOV_be-dd5yLHSQlAQsCuOTxK76ImK2A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP178411.RAZZKdCJ_tHPQzOV_be-dd5yLHSQlAQsCuOTxK76ImK2A130_assertion type Assertion NP178411.RAZZKdCJ_tHPQzOV_be-dd5yLHSQlAQsCuOTxK76ImK2A130_head.
- NP178411.RAZZKdCJ_tHPQzOV_be-dd5yLHSQlAQsCuOTxK76ImK2A130_assertion description "[High prevalence of the silencing of RELN pathway components and its reversal by histone deacetylase inhibitors suggest the importance of this pathway as a diagnostic and therapeutic target for pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP178411.RAZZKdCJ_tHPQzOV_be-dd5yLHSQlAQsCuOTxK76ImK2A130_provenance.
- NP178411.RAZZKdCJ_tHPQzOV_be-dd5yLHSQlAQsCuOTxK76ImK2A130_assertion evidence source_evidence_literature NP178411.RAZZKdCJ_tHPQzOV_be-dd5yLHSQlAQsCuOTxK76ImK2A130_provenance.
- NP178411.RAZZKdCJ_tHPQzOV_be-dd5yLHSQlAQsCuOTxK76ImK2A130_assertion SIO_000772 16472607 NP178411.RAZZKdCJ_tHPQzOV_be-dd5yLHSQlAQsCuOTxK76ImK2A130_provenance.
- NP178411.RAZZKdCJ_tHPQzOV_be-dd5yLHSQlAQsCuOTxK76ImK2A130_assertion wasDerivedFrom lhgdn-20090331 NP178411.RAZZKdCJ_tHPQzOV_be-dd5yLHSQlAQsCuOTxK76ImK2A130_provenance.
- NP178411.RAZZKdCJ_tHPQzOV_be-dd5yLHSQlAQsCuOTxK76ImK2A130_assertion wasGeneratedBy ECO_0000203 NP178411.RAZZKdCJ_tHPQzOV_be-dd5yLHSQlAQsCuOTxK76ImK2A130_provenance.